@article{d9c5a49b46f5417b8bb34f46c3433a25,
title = "Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection",
abstract = "Chronic granulomatous disease (CGD) is characterized by life-threatening bacterial and fungal infections. Treatment with posaconazole led to a complete response in 7 of 8 patients with CGD with invasive mold infections (7 proven cases and 1 possible case) after failure or intolerance of treatment with standard antifungal agents. In this preliminary study, salvage treatment with posaconazole was safe and effective.",
author = "Segal, {Brahm H.} and Barnhart, {Lisa A.} and Anderson, {Victoria L.} and Walsh, {Thomas J.} and Malech, {Harry L.} and Holland, {Steven M.}",
note = "Funding Information: Departments of 1Medicine and 2Immunology, Division of Infectious Diseases, Roswell Park Cancer Institute, Buffalo, New York; and 3Laboratory of Clinical Infectious Diseases and 4Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, and 5Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland",
year = "2005",
month = jun,
day = "1",
doi = "10.1086/430068",
language = "English (US)",
volume = "40",
pages = "1684--1688",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "11",
}